Ziwei Du

971 total citations
24 papers, 593 citations indexed

About

Ziwei Du is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ziwei Du has authored 24 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ziwei Du's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Protein Degradation and Inhibitors (3 papers). Ziwei Du is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Protein Degradation and Inhibitors (3 papers). Ziwei Du collaborates with scholars based in China, Canada and Singapore. Ziwei Du's co-authors include Xueshun Xie, Youxin Zhou, Yulun Huang, Guilin Chen, Xuetao Li, Hangzhou Wang, Yongxin Wei, Tianquan Yang, Yanyan Li and Fan Meng and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Environmental Health Perspectives.

In The Last Decade

Ziwei Du

24 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziwei Du China 14 359 220 55 53 47 24 593
Xiang Cheng China 13 305 0.8× 138 0.6× 44 0.8× 74 1.4× 32 0.7× 34 629
Lianshu Ding China 14 457 1.3× 201 0.9× 80 1.5× 59 1.1× 46 1.0× 38 825
Uday P. Pratap United States 15 260 0.7× 76 0.3× 28 0.5× 63 1.2× 69 1.5× 49 682
Xuebo Yan China 12 228 0.6× 68 0.3× 35 0.6× 133 2.5× 42 0.9× 28 557
Wan Fu China 16 334 0.9× 79 0.4× 35 0.6× 106 2.0× 37 0.8× 21 696
Melissa Schepers Netherlands 14 406 1.1× 123 0.6× 34 0.6× 74 1.4× 69 1.5× 34 971
Dan Lv China 12 207 0.6× 35 0.2× 69 1.3× 112 2.1× 53 1.1× 16 461
Devin T. Rosenthal United States 11 452 1.3× 124 0.6× 17 0.3× 43 0.8× 63 1.3× 12 802
Xiaohang Che China 15 257 0.7× 54 0.2× 36 0.7× 56 1.1× 72 1.5× 23 677
Tommi Kainu Finland 17 298 0.8× 76 0.3× 20 0.4× 134 2.5× 29 0.6× 21 736

Countries citing papers authored by Ziwei Du

Since Specialization
Citations

This map shows the geographic impact of Ziwei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziwei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziwei Du more than expected).

Fields of papers citing papers by Ziwei Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziwei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziwei Du. The network helps show where Ziwei Du may publish in the future.

Co-authorship network of co-authors of Ziwei Du

This figure shows the co-authorship network connecting the top 25 collaborators of Ziwei Du. A scholar is included among the top collaborators of Ziwei Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziwei Du. Ziwei Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Si, et al.. (2025). PROTACs coupled with oligonucleotides to tackle the undruggable. Bioanalysis. 17(4). 261–276. 2 indexed citations
2.
Yan, Si, Wei Luo, Mengwei Xu, et al.. (2024). PROTAC technology: From drug development to probe technology for target deconvolution. European Journal of Medicinal Chemistry. 276. 116725–116725. 37 indexed citations
3.
Xu, Mengwei, Zhaofang Bai, Baocheng Xie, et al.. (2024). Marine-Derived Bisindoles for Potent Selective Cancer Drug Discovery and Development. Molecules. 29(5). 933–933. 13 indexed citations
4.
Gao, Yang, et al.. (2024). Arctigenin Induces Apoptosis in Melanoma Cells by Reducing the Expression of BCL-2 and VEGF. Transplantation Proceedings. 56(2). 448–452. 2 indexed citations
5.
Deng, Yanan, et al.. (2024). The Notch1/Hes1 pathway regulates Neuregulin 1/ErbB4 and participates in microglial activation in rats with VPA-induced autism. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 131. 110947–110947. 6 indexed citations
6.
7.
Li, Yanfang, Liping Ma, Yanan Deng, et al.. (2023). The Notch1/Hes1 signaling pathway affects autophagy by adjusting DNA methyltransferases expression in a valproic acid-induced autism spectrum disorder model. Neuropharmacology. 239. 109682–109682. 11 indexed citations
8.
Sun, Nan, Yajuan Qin, Xu Chu, et al.. (2022). Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN. Science. 378(6618). 390–398. 64 indexed citations
9.
Liu, Mengying, Lulu Wei, Xian‐Hui Zhu, et al.. (2022). Prenatal stress modulates HPA axis homeostasis of offspring through dentate TERT independently of glucocorticoids receptor. Molecular Psychiatry. 28(3). 1383–1395. 16 indexed citations
10.
Li, Liandi, Muhammad Naveed, Ziwei Du, et al.. (2021). Abnormal expression profile of plasma-derived exosomal microRNAs in patients with treatment-resistant depression. Human Genomics. 15(1). 55–55. 35 indexed citations
11.
Zhang, Wang, Jingya Li, Xiaochen Wei, et al.. (2021). Effects of dibutyl phthalate on lipid metabolism in liver and hepatocytes based on PPARα/SREBP-1c/FAS/GPAT/AMPK signal pathway. Food and Chemical Toxicology. 149. 112029–112029. 54 indexed citations
12.
Zhang, Jing, Qigang Zhou, Muhammad Naveed, et al.. (2021). Agomelatine: An Astounding Sui-generis Antidepressant?. Current Molecular Pharmacology. 15(7). 943–961. 9 indexed citations
13.
Hu, Yuan, Yanyan Li, Chun Wu, et al.. (2017). MicroRNA-140-5p inhibits cell proliferation and invasion by regulating VEGFA/MMP2 signaling in glioma. Tumor Biology. 39(4). 3726131355–3726131355. 38 indexed citations
14.
Liu, Lijie, Fanfan Wang, Ziwei Du, et al.. (2016). Effects of Noise Exposure on Systemic and Tissue-Level Markers of Glucose Homeostasis and Insulin Resistance in Male Mice. Environmental Health Perspectives. 124(9). 1390–1398. 27 indexed citations
15.
Cheng, Zhe, Xuetao Li, Yong Han, et al.. (2015). MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma. Journal of Experimental & Clinical Cancer Research. 34(1). 27–27. 68 indexed citations
16.
Li, Xuetao, Hangzhou Wang, Tianquan Yang, et al.. (2015). miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Cellular and Molecular Neurobiology. 35(5). 679–687. 97 indexed citations
17.
Wu, Tingfeng, Wei Zhang, Guilin Chen, et al.. (2012). UHRF2 mRNA Expression is Low in Malignant Glioma but Silencing Inhibits the Growth of U251 Glioma Cells in vitro. Asian Pacific Journal of Cancer Prevention. 13(10). 5137–5142. 15 indexed citations
18.
Zhou, Youxin, Tingfeng Wu, Jinming Chen, et al.. (2012). A novel gene RNF138 expressed in human gliomas and its function in the glioma cell line U251.. SHILAP Revista de lepidopterología. 35(3). 167–78. 14 indexed citations
19.
Li, Xiao‐Nan, Ziwei Du, & Qiang Huang. (1996). Modulation effects of hexamethylene bisacetamide on growth and differentiation of cultured human malignant glioma cells. Journal of neurosurgery. 84(5). 831–838. 17 indexed citations
20.
Li, Xiao‐Nan, Qiang Huang, & Ziwei Du. (1992). Methodologic study of direct preparation for chromosome analysis of human solid brain tumors. Cancer Genetics and Cytogenetics. 58(2). 160–164. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiang Cheng Breakdown of academic impact, for papers by Lianshu Ding Breakdown of academic impact, for papers by Uday P. Pratap Breakdown of academic impact, for papers by Xuebo Yan Breakdown of academic impact, for papers by Wan Fu Breakdown of academic impact, for papers by Melissa Schepers Breakdown of academic impact, for papers by Dan Lv Breakdown of academic impact, for papers by Devin T. Rosenthal Breakdown of academic impact, for papers by Xiaohang Che Breakdown of academic impact, for papers by Tommi Kainu
Rankless by CCL
2026